{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:17:00Z","timestamp":1787242620123,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6460,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1093\/annonc\/mdf134","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:59:57Z","timestamp":1027709997000},"page":"789-795","source":"Crossref","is-referenced-by-count":75,"title":["Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Oncologie P\u00e9diatriqueLMB89 protocol"],"prefix":"10.1016","volume":"13","author":[{"given":"C.","family":"Patte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sakiroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ansoborlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Baruchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Plouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Pacquement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Babin-Boilletot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdf134_bb0010","series-title":"Metabolic emergencies","first-page":"2134","article-title":"Cancer: Principles and Practice of Oncology","author":"Warrell","year":"1993"},{"key":"10.1093\/annonc\/mdf134_bb0015","first-page":"273","article-title":"Tumor lysis syndrome","volume":"13","author":"Arrambide","year":"1993","journal-title":"Semin Nephrol"},{"key":"10.1093\/annonc\/mdf134_bb0020","first-page":"49","article-title":"Acute tumor lysis syndrome: assessment and nursing implications","volume":"20","author":"Stucky","year":"1993","journal-title":"Oncol Nurs Forum"},{"key":"10.1093\/annonc\/mdf134_bb0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/jama.1965.03090010007001","article-title":"Prevention of hyperuricemia in leukemia and lymphoma: use of allopurinol, a xanthine oxidase inhibitor","volume":"193","author":"Krakoff","year":"1965","journal-title":"J Am Med Assoc"},{"key":"10.1093\/annonc\/mdf134_bb0030","series-title":"Cancer Chemotherapy: Principles and Practice","first-page":"408","article-title":"Allopurinol","author":"Hande","year":"1990"},{"key":"10.1093\/annonc\/mdf134_bb0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM196603032740902","article-title":"Use of allopurinol for prevention and control of hyperuricaemia in patients with neoplastic disease","volume":"274","author":"DeConti","year":"1966","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdf134_bb0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF00860751","article-title":"Tumor lysis syndrome: pathogenesis and management","volume":"9","author":"Jones","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"10.1093\/annonc\/mdf134_bb0045","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJM197008132830708","article-title":"Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol","volume":"283","author":"Band","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdf134_bb0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/bjc.1998.432","article-title":"Advances in the management of malignancy-associated hyperuricemia","volume":"77","author":"Mahmoud","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdf134_bb0055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-3476(82)80259-X","article-title":"Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia","volume":"100","author":"Masera","year":"1982","journal-title":"J Pediatr"},{"key":"10.1093\/annonc\/mdf134_bb0060","first-page":"1199","article-title":"L\u2019urate-oxydase dans le traitement des hemopathies malignes","volume":"29","author":"Gardais","year":"1976","journal-title":"Quest Med"},{"key":"10.1093\/annonc\/mdf134_bb0065","first-page":"1093","article-title":"Utilisation de l\u2019urate-oxydase dans la prevention et le traitement des hyperuricemies dans 20 cas de leucose aigue de l\u2019enfant","volume":"12","author":"Robert","year":"1976","journal-title":"Rev Med Toulouse"},{"key":"10.1093\/annonc\/mdf134_bb0070","first-page":"479","article-title":"Le traitement des hyperuricemies en haematologie par l\u2019urate oxydase et l\u2019allopurinol","volume":"127","author":"Zittoun","year":"1976","journal-title":"Ann Med Interne"},{"key":"10.1093\/annonc\/mdf134_bb0075","first-page":"202","article-title":"Urate-oxidase as hypouricemic agent in a case of acute tumor lysis syndrome","volume":"7","author":"Jankovic","year":"1985","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1093\/annonc\/mdf134_bb0080","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1200\/JCO.2001.19.3.697","article-title":"Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma","volume":"19","author":"Pui","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf134_bb0085","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The SFOP LMB89 protocol: highly effective multi-agent chemotherapy tailored to tumor burden and initial response in 561 unselected children with B-cell lymphoma and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf134_bb0090","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1200\/JCO.1986.4.8.1219","article-title":"Improved survival rate in children with stage III and IV B cell non-Hodgkin\u2019s lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society","volume":"4","author":"Patte","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf134_bb0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.1991.9.1.123","article-title":"High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children","volume":"9","author":"Patte","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf134_bb0100","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/BF00866487","article-title":"Does kL\/PCr estimate GFR, or does GFR determine k?","volume":"6","author":"Schwartz","year":"1992","journal-title":"Pediatr Nephrol"},{"key":"10.1093\/annonc\/mdf134_bb0105","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1054\/bjoc.1999.1083","article-title":"Improved outcome in children with advanced stage B-cell non-Hodgkin\u2019s lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol","volume":"82","author":"Atra","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdf134_bb0110","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/bjc.1998.379","article-title":"Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin\u2019s lymphoma (B-NHL). Results of the UKCCSG 9003 protocol","volume":"77","author":"Atra","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdf134_bb0115","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.1996.14.4.1252","article-title":"Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study","volume":"14","author":"Bowman","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf134_bb0120","first-page":"279","article-title":"Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin\u2019s lymphoma and B-ALL","volume":"210","author":"Seidemann","year":"1998","journal-title":"Observations from the BFM trials. Klin Pediatr"},{"key":"10.1093\/annonc\/mdf134_bb0125","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/sj.leu.2400850","article-title":"Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies","volume":"11","author":"Pui","year":"1997","journal-title":"Leukemia"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419628917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419628917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/13\/5\/789\/530962\/mdf134.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:31:35Z","timestamp":1582165895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419628917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["S0923753419628917"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdf134","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}